Law Offices of Thomas J. Lamb

  • About Firm
  • Practice Areas
  • Free Case Evaluation
  • Quick Contact Form
  • Frequently Asked Questions
  • Attorney Tom Lamb

Camp Lejeune Claims for Veterans and Family Diagnosed With Cancers

August 16, 2022 By Law Offices of Thomas J. Lamb, P.A.

The Camp Lejeune Justice Act of 2022 allows for claims to be filed against the US Government seeking legal compensation for veterans and their family members who have been diagnosed with serious medical conditions, diseases, and cancers that are associated with harmful chemicals that were in the Camp Lejeune contaminated water they used during 1953 … [Read more...]

Filed Under: Camp Lejeune Tagged With: Camp Lejeune claims, Camp Lejeune Claims Review, Camp Lejeune contaminated water, Camp Lejeune Justice Act, cancers, Marine Corps Air Station New River, Marine Corps Base Camp Lejeune, MCAS New River, North Carolina

Xeljanz, Rinvoq, and Olumiant Safety Review by European Drug Regulator EMA

February 16, 2022 By Law Offices of Thomas J. Lamb, P.A.

The JAK inhibitors drug class safety issue has landed in Europe, as indicated by this European Medicines Agency (EMA) February 11, 2022, news item, “EMA starts safety review of Janus kinase inhibitors for inflammatory disorders”. This Xeljanz, Rinvoq, and Olumiant safety review by the EMA follows a December 2021 JAK inhibitors drug class safety FDA … [Read more...]

Filed Under: Unsafe Drugs Tagged With: cancers, cardiovascular deaths, cardiovascular events, Heart Attacks, Olumiant, Rinvoq, Strokes, Xeljanz

Xeljanz Safety Study Final Findings Presented in January 2022

February 4, 2022 By Law Offices of Thomas J. Lamb, P.A.

The Xeljanz safety study final findings from the so-called “ORAL Surveillance” trial ordered by the FDA were examined in this January 26, 2022 article, “Trial Data Confirm Heightened Risks With JAK Inhibitor”, by medical news reporter John Gever for MedPage Today. That January 2022 MedPage Today news report provides a “snapshot” of the current … [Read more...]

Filed Under: Unsafe Drugs Tagged With: cancers, cardiovascular events, Olumiant, Rinvoq, Xeljanz

Xeljanz Safety Alert for People Who Are (1) Older, (2) Current / Past Smokers, or (3) With Cardiovascular or Cancer Risk Factors

January 21, 2022 By Law Offices of Thomas J. Lamb, P.A.

This excerpt from the “Advisory – Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer” issued in January 2022 provides an overview of the Xeljanz drug safety issue, and how the Xeljanz side effects risks may also apply to Olumiant and … [Read more...]

Filed Under: Unsafe Drugs Tagged With: cancers, cardiovascular events, heart problems, lung cancer, lymphoma, Myocardial Infarction, Olumiant, Rinvoq, Xeljanz

Cancers, Blood Clots, Heart Problems, and Deaths Associated with Xeljanz, Olumiant, and Rinvoq

December 15, 2021 By Law Offices of Thomas J. Lamb, P.A.

We continue to monitor the pharmaceutical regulatory sector as well as the medical literature for developments as regards the increased risks of cancers, blood clots, heart problems, and deaths associated with Xeljanz, Olumiant, and Rinvoq. In December 2021 there was another JAK inhibitors drug class safety development, with Xeljanz, Olumiant, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: blood clots, cancers, heart problems, Olumiant, Rinvoq, Xeljanz

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

DrugInjuryLaw.com

DrugInjuryWatch.com

Asbestos-Mesothelioma.com

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2025 · Law Offices of Thomas J. Lamb, P.A.